Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Overactive Bladder Syndrome

NCT06024642 is registered in ClinicalTrials.gov with Imbrium Therapeutics as lead sponsor.

NCT NCT06024642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06024642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Overactive Bladder Syndrome
Lead sponsor
Imbrium Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2022
Completion date
May 21, 2024
Enrollment
51 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome